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1 |  INTRODUCTION
Application of noninvasive prenatal screening (NIPS) has 
increased rapidly worldwide and now accounts for a large 
proportion of prenatal screening tests for trisomy 21, trisomy 
18, trisomy 13, sex chromosomes, and an increasing number 
of microdeletions (Greene and Phimister, (2014); Van Opstal 
et al., 2018; Hui, Hutchinson, Poulton, & Halliday, 2017). 
By means of cell-free DNA genomic sequencing analysis, 
NIPS for trisomies 21, 18, and 13 achieves much better per-
formance than conventional standard screening tests, which 
are based on serological markers, maternal age, and maternal 
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Abstract
Background: To evaluate the impact of ultrasonography on identifying noninvasive 
prenatal screening (NIPS) false-negative aneuploidy.
Methods: Analysis of large population-based NIPS false-negative aneuploidy data 
comprising karyotypes, clinical outcomes, and ultrasound results.
Results: From December 2010 to July 2018, a total of 3,320,457 pregnancies were 
screened by NIPS performed in BGI; among them, 69 NIPS false-negative aneu-
ploidy cases with informed consent were confirmed, and ultrasound examination 
data for 48 cases were not available. Of the 21 cases with ultrasound results, 19 
(90.5%) had various abnormalities on ultrasound, and two (9.5%) cases were shown 
to be normal on ultrasound. Additionally, six of seven live-born fetuses (approxi-
mately 85.7%) were found to have abnormalities on ultrasound. Ventricular septal 
defects constituted the most frequently observed ultrasound abnormality type among 
the 21 NIPS false-negative aneuploidy cases.
Conclusion: Application of NIPS has increased rapidly worldwide and now ac-
counts for a large proportion of prenatal screening tests in China. This study suggests 
that ISUOG guideline should be followed practically, and structural abnormal ultra-
sound findings should not be neglected, even when NIPS produces a negative result. 
Combining NIPS with an ultrasound examination can further reduce the incidence of 
live births with aneuploidy.
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history (Hui et al., 2017). The American College of Medical 
Genetics and Genomics has recommended informing all 
pregnant women that NIPS is the most sensitive screening 
option for traditionally screened aneuploidies (i.e., Patau, 
Edwards, and Down syndromes; Gregg et al., 2016). The po-
tential impact of NIPS on the field of prenatal diagnosis and 
on the prevalence of live births with chromosomal abnormal-
ities is increasing dramatically since sequencing costs have 
been gradually decreasing and since government funding has 
increased (Oepkes et al., 2016).
Although the occurring rate of false-negative cases is 
very low, discordant findings between NIPS and prenatal 
diagnoses, which may result from a low fetal DNA fraction 
or fetoplacental mosaicism (Grati et al., 2014; Scott et al., 
2018), are still observed globally. There are case reports that 
ultrasonography, a powerful method for screening fetal aneu-
ploidy during pregnancy, may contribute to the identification 
of NIPS false-negative cases (Pan et al., 2014; Yang et al., 
2017). Abnormalities on ultrasound (US) are useful markers 
for detecting trisomy 21, trisomy 18, trisomy 13, sex chromo-
some aneuploidy  (SCA), rare autosomal trisomies (RATs), 
and even copy number variations, as reported previously 
(Beulen, Faas, Feenstra, Vugt, & Bekker, 2017; DeVore, 
2000; Shaffer et al., 2012). Clinically, the cardiac, neuro-
logic, gastrointestinal, musculoskeletal, and facial defects are 
the most common ultrasonographic structural abnormalities 
as reported previously (Ainsworth, Holman, Codsi, & Wick, 
2018; Rao & Platt, 2016), and nasal bone abnormalities, nu-
chal fold thickening, and hyperechoic bowel are useful at a 
fairly high detection rate for screening fetuses with trisomy 
21 (Sonek & Croom, 2014). However, reports on the quanti-
tative contribution of ultrasound toward identifying the geno-
types of NIPS false-negative cases are still limited.
The NIPS result represents the genotype of the fetus, 
whereas the ultrasound finding reflects the phenotype of the 
fetus. We aimed to assess the impact of ultrasound on NIPS 
false-negative aneuploidy based on real-world data from 
3,320,457 pregnancies screened from 2010 to 2018.
2 |  METHODS
2.1 | Study population and sample collection
From December 2010 to July 2018, a total of 3,320,457 preg-
nancies were screened by NIPS performed by BGI, among 
which 69 NIPS false-negative aneuploidy cases (with writ-
ten informed consent for research purposes) were confirmed 
by G-banded karyotyping or a chromosomal microarray 
(CMA) diagnosis. This study was approved by the insti-
tutional review board of BGI (BGI-IRB). The article was 
previously published as a preprint on BioRxiv, https://doi.
org/10.1101/748269.
NIPS and ultrasound examination were recommended 
for pregnancies according to the standard screening process 
(Bianchi et al., 2014). Whole-genome shallow massively 
parallel sequencing was performed in all cases at a depth of 
about 0.1 time. The z-score cutoff was set as 3 for calling 
trisomies. And, we are not using an assay to detect microdele-
tions due to the low sequencing depth. Thereafter, G-banded 
karyotyping or CMA diagnosis was highly recommended for 
cases that were high risk.
2.2 | Validation and follow-up of NIPS false-
positive or false-negative aneuploidy cases
The NIPS-positive results were followed up and further vali-
dated by G-banded karyotyping or CMA diagnosis, or fol-
low-up of clinical outcomes.
Meanwhile, both false-positive and false-negative NIPS re-
sults (for trisomy 21, 18, 13) were encouraged to be reported 
by offering each participant an insurance as a part of the test. 
In the case of a false-positive NIPS result, the insurance pol-
icy requires refunding the cost of the invasive tests. For each 
false-negative NIPS case with clinically confirmed aneuploidy 
before or after live birth, the insurance policy requires paying 
CNY 20,000 or CNY 400,000 to the patient, respectively.
The ultrasound examination results, if available, could 
be traced from the insurance materials. The unavailability of 
ultrasound information meant either that ultrasound was not 
performed or that the ultrasound results were not available 
from the insurance materials.
2.3 | Statistical analyses
Statistical analysis was performed using Student's t-test, and 
p < .05 was considered statistically significant. All statistical 
analyses were conducted using R, version 3.4.3.
2.4 | Data availability statement
All data generated or analyzed during this study are included in 
this published article (and its supplementary information files).
3 |  RESULTS
The enrollment, clinical follow-up, and outcomes of the 
false-negative cases participating in NIPS and ultrasound are 
presented in Figure 1. Of the 69 NIPS false-negative preg-
nancies (Table  S1), 21 cases had available ultrasound ex-
amination information, and 48 cases did not have available 
information. The median gestational age (GA) of the 21 NIPS 
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false-negative cases that underwent ultrasound examina-
tions was 24.8 weeks; herein, the second trimester GA group 
(66.7%) was the most predominant (Table S2). The median 
maternal age was 30 years, and most of the women, 12 of 21 
cases (57.1%), were not more than 30 years old (Table S2).
Regarding the 21 cases with ultrasound information 
(Figure 1; Table 1), a total of 19 pregnancies were found to 
have abnormalities by ultrasound examination, whereas only 
two pregnancies were normal by ultrasound examination 
(Figure 1). That is, 90.5% of the cases with ultrasound infor-
mation (19 of 21) and at least 27.5% of the total cohort (19 
of 69) were NIPS false-negative cases that could potentially 
be avoided by means of a combination of NIPS and an ul-
trasound examination, followed by G-banded karyotyping or 
CMA diagnosis, which would probably not increase the risk 
of fetal loss.(Malan et al., 2018) It did not escape our notice 
that six of seven children born had abnormal ultrasound find-
ings during pregnancy; that is, six of seven NIPS false-neg-
ative cases born could have potentially been identified by 
means of the ultrasound examination (Figure  1; Table  1). 
The abnormal ultrasound findings for the six children born 
included small head circumference, lateral ventriculomegaly 
(11.2/10.2 mm), ventricular septal defect, aortarctia, tricus-
pid moderate regurgitation, nasal bones dysplasia, short fem-
ora, short humeri, bilateral renal pelvis dilation (4.9/4.0 mm), 
polyhydramnios, and single umbilical artery (Table 1).
The features of abnormal ultrasound findings and the cor-
responding karyotyping genotypes for the 19 cases (Table 1) 
were analyzed and summarized in Figure 2. Congenital car-
diovascular defects, skeletal malformations, and brain and 
nervous system defects were the most frequently detected 
organic system abnormalities (Figure  2a), and ventricular 
septal defects (7 of 19 cases) were the most frequently ob-
served ultrasound abnormalities (Figure 2a) among the NIPS 
false-negative aneuploidy cases. There is a preponderance of 
the trisomy 18 genotype over the trisomy 21 genotype among 
all of the top six ultrasound-based systematic abnormalities, 
including the cardiovascular, skeletal, brain, and nervous, uri-
nary, fetal appendage, and craniofacial systems (Figure 2a). 
Among the defects in the cardiovascular system, ventricular 
septal defect, pulmonary artery enlargement, dilated right 
heart, hypoplastic left heart, and double outlets of the right 
ventricle could be strong ultrasonic markers for trisomy 18, 
whereas an atrioventricular septal defect suggests trisomy 21. 
Additionally, tricuspid regurgitation and aortarctia could be 
ultrasonic findings for either trisomy 18 or trisomy 21. As 
shown in Figure  2b, the fetuses with trisomy 18 tended to 
show abnormal findings by ultrasound at an earlier average 
GA (24.5 versus. 27.8  weeks) than those with trisomy 21; 
however, the difference was not significant (p value was .19).
4 |  DISCUSSION
With the large population-based data, this study analyzes 
the impact of prenatal ultrasound examination on NIPS 
false-negative cases. This report focuses on cases between 
December 2010 and July 2018 in China, and these data may 
also have significance in other countries as a reference. Even 
though the occurring rate of NIPS false-negative cases was 
low, we aimed to investigate the false-negative case data 
and explore a viable method to supplement NIPS to further 
reduce the live birth prevalence of aneuploidy, or help the 
families to plan for care after birth.
4.1 | Combination of NIPS and ultrasound
NIPS is the most accurate and powerful prenatal screening 
method for Patau, Edwards, and Down syndromes to date, 
F I G U R E  1  Enrollment, clinical follow-up, and outcome classification of the false-negative cases participating in the NIPS and ultrasound 
examinations
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according to a previous global report (Chitty et al., 2016; 
Gregg et al., 2016). Nevertheless, NIPS can still produce 
false-negative chromosomal aneuploidy results for fetuses, 
as well as live births when the probability of a live birth 
(approximately 20% of trisomy 21 fetuses may progress to 
term delivery; Antonarakis, Lyle, Dermitzakis, Reymond, 
& Deutsch, 2004) is taken into account. NIPS false-negative 
findings may occur due to various reasons, including a low 
fetal DNA fraction and fetoplacental mosaicism. As was re-
ported previously, mosaic trisomy can be accurately detected 
T A B L E  1  Characteristics of the 21 NIPS false-negative cases
Case
Age 
(years)
Gestational agea 
(weeks) Ultrasound results Genotype Outcome
1 28 23.0 Bilateral renal pelvis dilation (4.9/4.0 mm) 47,XN,+21 Born
2 31 31.6 Small head circumference; aortarctia, tricuspid 
moderate regurgitation; short femora
47,XN,+21 Born
3 28 N.A Nasal bones dysplasia 47,XN,+21 Born
4 27 27.0 Lateral ventriculomegaly (11.2/10.2 mm) 47,XN,+21 Born
5 32 25.0 Short humeri 47,XN,+21 Born
6 29 N.A Normal 47,XN,+21 Born
7 30 N.A Ventricular septal defect; polyhydramnios; single 
umbilical artery
47,XN,+18 Born
8 27 27.3 Absence of both the fingers and the metacarpal 
bones; intrauterine growth restriction
47,XN,+21 Abortion
9 27 24.4 Completely atrioventricular septal defect mos 47,XN, 
+21[45]/46,XN[40]
Abortion
10 28 23.0 Multiple malformation (Not specified) 47,XN,+18 Abortion
11 35 28.4 Bilateral choroid plexus cyst, lemon sign; 
ventricular septal defect; left wrist drop, abnormal 
position of fingers, scoliosis; left dysplastic kidney
47,XN,+18 Abortion
12 35 23.3 Multiple malformation (Not specified) 47,XN,+18 Abortion
13 33 24.9 Cauda cerebelli dysplasia; ventricular septal defect, 
dilated right heart; pulmonary artery enlargement; 
single umbilical artery
47,XN,+18 Abortion
14 30 16.0 Low-set ears, edema in the posterior head and neck 47,XN,+18 Abortion
15 29 24.7 Cauda cerebelli dysplasia, absence of the splenium 
corpus callosum; ventricular septal defect, 
aortarctia; overriding fingers
47,XN,+18 Abortion
16 37 25.1 Multiple malformation (Not specified) 47,XN,+18 Abortion
17 28 25.3 Cauda cerebelli dysplasia; ventricular septal defect; 
pulmonary artery enlargement; micromandible; 
rocker-bottom foot, overriding fingers; single 
umbilical artery
47,XN,+18 Abortion
18 31 24.1 Ventricular septal defect, tricuspid slight 
regurgitation, hypoplastic left heart, double outlets 
of right ventricle; overriding fingers; unilateral 
hydronephrosis; cyst of left ureter tube; single 
umbilical artery
47,XN,+18 Abortion
19 35 29.9 Small transverse cerebellar diameter, bilateral 
choroid plexus cyst, cavum veli interpositi 
dilatation; short femora, short humeri; intrauterine 
growth restriction
47,XN,+18 Abortion
20 35 24.3 Ventricular septal defect; cross-foot 47,XN,+18 Abortion
21 24 12.3 Normal 47,XN,+18 Miscarriage
Abbreviation: N.A, not available.
aThe examination test date of ultrasound. 
   | 5 of 7LI et aL.
by NIPS only when the fraction of fetoplacental mosaicism is 
higher than 70% (Grati et al., 2014).
The combination of NIPS and an ultrasound exam-
ination may further reduce the risk for false-negative fe-
tuses and live births. We observed a significant proportion 
(90.5%, 19 of 21 cases with ultrasound data) of NIPS 
false-negative cases (at least 27.5% of the total cohort [19 
of 69], if all of the US cases without available data had 
normal ultrasound results or 97.1% [67 of 69], if all of the 
ultrasound cases without available data had abnormal ul-
trasound results) could be potentially avoided by means of 
a combination of NIPS and an ultrasound examination, fol-
lowed by G-banded karyotyping or CMA diagnosis, which 
would probably not increase the risk of fetal loss, accord-
ing to an updated large population study (Malan et al., 
2018). Clinicians should pay additional attention to the top 
ultrasound findings indicating congenital cardiovascular 
defects, skeletal malformations, brain and nervous system 
defects, urinary malformations, and especially ventricular 
septal defects, which are the most common abnormal find-
ings on ultrasound among NIPS false-negative cases (Figure 
S2). In addition, special attention should be paid to abnor-
mal signs on ultrasound, namely small head circumference, 
lateral ventriculomegaly (11.2/10.2 mm), ventricular septal 
defect, aortarctia, tricuspid moderate regurgitation, nasal 
bones dysplasia, short femora, short humeri, bilateral renal 
pelvis dilation (4.9/4.0  mm), polyhydramnios, and single 
umbilical artery, since, surprisingly, six NIPS false-nega-
tive fetuses (five trisomy 21 cases and one trisomy 18 case) 
with these ultrasound signs were born alive because these 
abnormal ultrasound findings were overlooked (Table  1). 
Five of these cases (cases 2, 3, 4, 5, and 7) with strong 
T A B L E  1  (Continued)
F I G U R E  2  The distribution of abnormal ultrasound phenotypes. (a) Histogram showing the number of distinct ultrasound abnormal 
phenotypes based on affected organ systems, as well as the distinct ultrasound findings and corresponding genotypes. (b) Boxplot comparison 
of the gestational age for the abnormal ultrasound findings among five trisomy 21 fetuses and 11 trisomy 18 fetuses. Statistical analysis was 
performed using Student's t-test, and the p value was .19
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ultrasound markers (in isolation or with additional anom-
alies) would be advised by clinicians to undergo an inva-
sive diagnosis (Gilmore et al., 2008), while the other case 
(case 1) with a soft ultrasound marker may not be advised 
to undergo an invasive diagnosis by the clinician in China 
according to the ISUOG guidelines (Salomon et al., 2017; 
Society for Maternal-Fetal Medicine, Biggio, & Kuller, 
2017). Reasonably, all five fetuses with soft markers (ul-
trasound findings), including nasal bone dysplasia, lateral 
ventriculomegaly (11.2/10.2  mm), polyhydramnios, and 
bilateral renal pelvis dilation (4.9/4.0  mm), successfully 
progressed to term delivery, indicating that these types of 
ultrasound findings are inclined to be overlooked more fre-
quently (Table 1).
This implies the complementary role of ultrasonogra-
phy with NIPS to achieve a better prenatal screening per-
formance. Clinically, abnormal ultrasound findings should 
not be neglected when performing G-banded karyotyping 
or the CMA diagnosis, even when NIPS results in a nega-
tive result.
Our study had the following limitations. First, the ultra-
sound results were not available for all of the 69 cases, so we 
could not accurately evaluate the quantitative contributions 
of ultrasound toward identifying NIPS false-negative cases. 
The rate of abnormal ultrasound findings among the NIPS 
false-negative cases may be approximately 90.5% (19 of 21 
cases with ultrasound data), fluctuating between 27.5%, (at 
least 19 of 69, if all of the ultrasound cases without available 
data had ultrasound normal results) and 97.1% (at most 67 of 
69, if all of the ultrasound cases without available data had 
ultrasound abnormal results). Second, accurate follow-up of 
some clinical information was not performed. Specifically, 
the reasons that six cases with prenatal abnormal findings on 
ultrasound were born were undetermined in our study, and 
these reasons may be that the clinicians overlooked the find-
ings or that the patients declined pregnancy termination. On 
the latter situation, ultrasound may not be helpful for further 
reducing the live birth incidence of false-negative aneuploidy 
cases, but could be helpful for the families to plan for care 
after birth. Lastly, detailed clinical ultrasound information, 
such as the presence of multiple malformations (Table  1), 
was not available for all the cases because these details were 
not specified in the insurance materials.
5 |  CONCLUSION
Application of NIPS has increased rapidly worldwide and now 
accounts for a large proportion of prenatal screening tests in 
China. We observed that 19 of the 69 NIPS false-negative preg-
nancies were found to have abnormal findings on ultrasound, 
indicating that between at least 27.5% (if all of the ultrasound 
cases without available data had normal ultrasound results) 
and at most 97.1% (if all of the ultrasound cases without avail-
able data had abnormal ultrasound findings) false-negative 
cases could be potentially avoided by means of a combination 
of NIPS and ultrasonography, followed by G-banded karyo-
typing or a CMA diagnosis. Clinically, we should follow the 
ISUOG guidelines more strictly when abnormal ultrasound 
findings were accompanied with NIPS negative results. Based 
on all the information presented above, clinically, we may be 
more cautious about the abnormal ultrasound findings even 
though NIPS shows negative results.
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